Di Lorenzo G - Search Results

1

Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study.

Di Lorenzo G, Buonerba C, Bellelli T, Romano C, Montanaro V, Ferro M, Benincasa A, Ribera D, Lucarelli G, De Cobelli O, Sonpavde G, De Placido S. Di Lorenzo G, et al. Medicine (Baltimore). 2015 Dec;94(51):e2297. doi: 10.1097/MD.0000000000002297. Medicine (Baltimore). 2015. PMID: 26705213 Free PMC article.

2

Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.

Di Lorenzo G, Tortora G, D'Armiento FP, De Rosa G, Staibano S, Autorino R, D'Armiento M, De Laurentiis M, De Placido S, Catalano G, Bianco AR, Ciardiello F. Di Lorenzo G, et al. Clin Cancer Res. 2002 Nov;8(11):3438-44. Clin Cancer Res. 2002. PMID: 12429632

3

Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives.

Autorino R, Di Lorenzo G, Damiano R, De Placido S, D'Armiento M. Autorino R, et al. Among authors: di lorenzo g. Urol Int. 2003;70(1):1-14. doi: 10.1159/000067704. Urol Int. 2003. PMID: 12566808 Review.

4

External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life.

Di Lorenzo G, Autorino R, Ciardiello F, Raben D, Bianco C, Troiani T, Pizza C, De Laurentiis M, Pensabene M, D'Armiento M, Bianco AR, De Placido S. Di Lorenzo G, et al. Oncol Rep. 2003 Mar-Apr;10(2):399-404. Oncol Rep. 2003. PMID: 12579279 Review.

5

Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.

Di Lorenzo G, Autorino R, De Laurentiis M, Bianco R, Lauria R, Giordano A, De Sio M, D'Armiento M, Bianco AR, De Placido S. Di Lorenzo G, et al. Tumori. 2003 Jul-Aug;89(4):349-60. doi: 10.1177/030089160308900402. Tumori. 2003. PMID: 14606635 Review.

6

Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma.

De Sio M, Autorino R, Di Lorenzo G, Damiano R, Cosentino L, De Placido S, D'Armiento M. De Sio M, et al. Among authors: di lorenzo g. Urol Int. 2003;71(4):361-7. doi: 10.1159/000074086. Urol Int. 2003. PMID: 14646433 Review.

7

HER-2/neu receptor in prostate cancer development and progression to androgen independence.

Di Lorenzo G, Autorino R, De Laurentiis M, Cindolo L, D'Armiento M, Bianco AR, De Placido S. Di Lorenzo G, et al. Tumori. 2004 Mar-Apr;90(2):163-70. doi: 10.1177/030089160409000201. Tumori. 2004. PMID: 15237576 Review.

8

Expression of proto-oncogene c-kit in high risk prostate cancer.

Di Lorenzo G, Autorino R, D'Armiento FP, Mignogna C, De Laurentiis M, De Sio M, D'Armiento M, Damiano R, Vecchio G, De Placido S. Di Lorenzo G, et al. Eur J Surg Oncol. 2004 Nov;30(9):987-92. doi: 10.1016/j.ejso.2004.07.017. Eur J Surg Oncol. 2004. PMID: 15498646

9

Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer.

Di Lorenzo G, Pizza C, Autorino R, De Laurentiis M, Marano O, D'Alessio A, Cancello G, Altieri V, Tortora G, Perdonà S, Bianco AR, De Placido S. Di Lorenzo G, et al. Eur Urol. 2004 Dec;46(6):712-6. doi: 10.1016/j.eururo.2004.08.022. Eur Urol. 2004. PMID: 15548437 Clinical Trial.

10

FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder.

Di Lorenzo G, Autorino R, Giordano A, Giuliano M, D'Armiento M, Bianco AR, De Placido S. Di Lorenzo G, et al. Jpn J Clin Oncol. 2004 Dec;34(12):747-50. doi: 10.1093/jjco/hyh132. Jpn J Clin Oncol. 2004. PMID: 15640506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

782 results

Search Page

Filters